Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 6, 2014-- Covidien plc (NYSE: COV) will present at the Barclays Global Healthcare Conference 2014 in Miami on March 13. Charles J. Dockendorff, executive...
DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 3, 2014-- Covidien plc (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care...
HARTFORD, Conn. and MINNEAPOLIS, March 3, 2014 - Beginning this month, Aetna (NYSE: AET) and Medtronic, Inc. (NYSE: MDT) will work with doctors in a new program to reach up to 300 fully insured...
MINNEAPOLIS - Mar 6, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Barclays Global Healthcare Conference on...
DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 27, 2014-- Covidien plc (NYSE: COV) today announced that it has closed its acquisition of Given Imaging Ltd., providing the company additional scale and...
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
MINNEAPOLIS - Feb 27, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Cowen and Company 34th Annual Healthcare...
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 26, 2014-- Covidien plc (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care...
DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 24, 2014-- Covidien plc (NYSE: COV) will present at the Raymond James 35th Annual Institutional Investors Conference in Orlando, Fla., on March 3. Charles J....
MINNEAPOLIS -- February 21, 2014 -- On February 20, 2014, Medtronic, Inc. (NYSE: MDT) registered an offering of $250 million principal amount of its 0.875% Senior Notes due 2017, $250 million...
MINNEAPOLIS - Feb. 20, 2014 - Continuing its leadership in advanced pacing technology and device miniaturization, Medtronic, Inc. (NYSE: MDT), today announced the first U.S. implant of the world's...
MINNEAPOLIS - February 19, 2014 -Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance, CE (Conformité Européenne) Mark, and the global launch of...
MINNEAPOLIS - Feb. 18, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2014, which ended January 24, 2014. The company reported worldwide...
DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 18, 2014-- Covidien plc (NYSE: COV) will present at two upcoming investor conferences -- the Citi 2014 Global Healthcare Conference on Feb. 25 and the RBC...
MINNEAPOLIS - Feb 18, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 2014 Citi Global Healthcare Conference on...
(Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - February 14, 2014 - Medtronic, Inc. (NYSE: MDT), today announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial...
MINNEAPOLIS -- Feb. 13, 2014 -- Aligned with its commitment to provide innovative medical technology for the interventional treatment of peripheral artery disease, Medtronic, Inc. (NYSE: MDT) has...
MINNEAPOLIS - February 13, 2014 - Medtronic, Inc. (NYSE:MDT) has begun distribution of i-port Advance® as part of a continued focus to provide meaningful therapy management solutions for people...
MINNEAPOLIS - February 13, 2014 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.28 per share of the Company's common stock. The quarterly dividend...
MINNEAPOLIS - Feb. 11, 2014 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the third quarter of its fiscal year 2014 on Tuesday, February 18, 2014. A news...
(Thomson Reuters ONE via COMTEX) --Latest Continuous Glucose Monitoring Sensor Provides Improved Comfort and Sensing Experience VIENNA - February 6, 2014 - Medtronic, Inc. (NYSE:MDT) today...
DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 6, 2014-- Covidien plc. (NYSE:COV) announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the company’s Endo GIA™...
DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 4, 2014-- Covidien plc (NYSE: COV) will present at the 2014 Leerink Global Healthcare Conference in New York on Feb. 12. Coleman N. Lannum, vice president,...